logo
Select company
Select metric
-17.86%EBITDA Margin
VS
Market
20
Sector
53
Industry
77
History
96
$ 9.52Close
$ 6.07 - $ 28.04 52-Week Range
Ticker Information

Ticker

ARVN

Company Name

ARVINAS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ARVINAS INC - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ARVN - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -66.6M-17.86%$ 372.8M
3/31/2025$ -39.8M-9.32%$ 426.9M
12/31/2024$ -191.7M-72.78%$ 263.4M
9/30/2024$ -299.4M-185.85%$ 161.1M
6/30/2024$ -314.7M-337.3%$ 93.3M
3/31/2024$ -346.7M-486.26%$ 71.3M
12/31/2023$ -359.7M-458.22%$ 78.5M
9/30/2023$ -278.2M-166.39%$ 167.2M
6/30/2023$ -277.8M-170.53%$ 162.9M
3/31/2023$ -277.2M-198.43%$ 139.7M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ARVINAS INC's latest trailing twelve months (TTM) EBITDA % stands at -389.37%.
  • Over the past 5 years, ARVINAS INC's average EBITDA % has been -326.43%.
  • The median EBITDA % for ARVINAS INC during this period was -274.37%
  • ARVINAS INC reached its highest EBITDA % over the past 5 years at -9.32%.
  • The lowest EBITDA % recorded by ARVINAS INC in the same timeframe -769.38%

ARVINAS INC's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
RIGL : RIGEL PHARMACEUTICALS INC 40.8%MRVI : MARAVAI LIFESCIENCES HOLDINGS INC -46.88%KROS : KEROS THERAPEUTICS INC 13.13%SNDA : SONIDA SENIOR LIVING INC 16.03%CSTL : CASTLE BIOSCIENCES INC 9.41%RGNX : REGENXBIO INC -83.4%XNCR : XENCOR INC -83.96%ANGO : ANGIODYNAMICS INC -2.07%NKTR : NEKTAR THERAPEUTICS -125.65%KURA : KURA ONCOLOGY INC -231.11%

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for ARVINAS INC is calculated as follows: EBITDA [ $ -95.31M ] / Revenues [ $ 24.48M ]
(=) EBITDA % [ -389.37% ]

ARVN - EBITDA Margin, Last 5 years

-769.38%

Minimum

Sep 30, 2021

-9.32%

Maximum

Mar 31, 2025

-326.43%

Average

-274.37%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-75.07%
max97.73%
average16.12%
median14.72%
std26.88%